Raffit Hassan

12PUBLICATIONS
65CO-AUTHORS
Biomedical imagingMolecular targetsElectrical circuits and systemsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 10, 2025
Targeting uPARAP with an Antibody-Drug Conjugate Exhibits Efficacy against Mesothelioma and Synergizes with Cisplatin.

Pınar Çakılkaya, Ida Marie Egeland Larsen, Qun Jiang

|Jun 26, 2025
Temporal mapping of the anti-tumor effects of nanobody-based MSLN.CAR-T cell therapy in metastatic solid tumors.

Chaido Stathopoulou, Mingming Zhao, Qun Jiang

|May 02, 2025
Robust differentiation of NK cells from MSLN.CAR-IL-15-engineered human iPSCs with enhanced antitumor efficacy against solid tumors.

Qun Jiang, Weiming Yu, James Ma

|Jan 08, 2025
Treatment of Pleural Mesothelioma: ASCO Guideline Update.

Hedy L Kindler, Nofisat Ismaila, Lyudmila Bazhenova

|Nov 16, 2024
Persistence of activated anti-mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomas.

Sameer Mir, Abhilash Venugopalan, Jingli Zhang

|Jul 27, 2023
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results.

Raffit Hassan, Marcus Butler, Roisin E O'Cearbhaill

Pageof 2

Frequent Collaborators

4 joint publications

Qun Jiang

4 joint publications

Jingli Zhang

3 joint publications

Ira Pastan

2 joint publications

Nofisat Ismaila